ISHLT: The International Society for Heart & Lung Transplantation

Boards & Committees - I2C2

INTERNATIONAL & INTER-SOCIETY COORDINATION COMMITTEE (I2C2)
COMMITTEE LEADERSHIP	ABOUT THE COMMITTEE
CORE LEADERS	I2C2 MEETINGS @ ISHLT 2013 in Montréal: Wednesday, April 24, 1:15-2:15 PM Room 512D, Palais des congrès de Montréal The I2C2 has two major areas of interest: 1. Emerging International Issues The I2C2 will take a leadership role in reacting to important international developments of interest to the membership of ISHLT. The group will work closely with the Board of Directors and Councils to develop timely and appropriate responses and policies for the benefit of the Society and the patients we serve. 2. Inter-Societal & International Outreach It is a pivotal role of I2C2 to develop formal relationships with other Societies where mutual benefits may be attained, membership shared, and common goals exist. There are many areas of benefit to ISHLT members where collaborative working can take place on a formal basis and meaningful liaisons developed. This role will also include establishing external representation for ISHLT on the international stage and ensuring that we exert influence in the interests of ISHLT's wider aims. With the permission of the Board, the I2C2 will be a policy-making group where relevant. For more information, visit I2C2--Bringing ISHLT to the World.
CO-CHAIR Stephen C. Clark, MD Freeman Hospital Newcastle Upon Tyne, UNITED KINGDOM 44-191233-6161 s.c.clark@ncl.ac.uk Bio coming soon... CO-CHAIR Andreas Zuckermann, MD University of Vienna Vienna, AUSTRIA 43-1-40400-5643 andreas.zuckermann@meduniwien.ac.at Bio coming soon... Lori J. West, MD, DPhil University of Alberta Edmonton, Alberta, CANADA 780-492-3200 ljwest@ualberta.ca Dr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist. Maria G. Crespo-Leiro, MD Hospital Universitario A Coruña La Coruña, SPAIN 34-981-178-304 Marisa.Crespo.Leiro@sergas.es Maria G (Marisa) Crespo-Leiro, MD, PhD, FESC, is the Medical Director of the Advanced Heart Failure Transplant Unit at the Hospital Universitario A Coruña, La Coruña, Spain. She obtained her MD degree at the University of Santiago de Compostela, her specialization in cardiology at Clinica Puerta de Hierro in Madrid and her PhD from Universidad Autónoma de Madrid. Since 1993 she has been working in the Heart Division at the Hospital Universitario A Coruña (formerly the Hospital Universitario Juan Canalejo) in La Coruña, where she is also Associate Professor of Medicine. Her main fields of research interest are heart failure and heart transplantation. Diego H. Delgado, MD, MSc Toronto General Hospital Toronto, Ontario, Canada 416-340-3940 diego.delgado@uhn.on.ca Dr. Diego Delgado is a Transplant Cardiologist at University Health Network (UHN), Director of the Heart Failure Clinical Trial Group at UHN, and an Associate Professor of the Division of Cardiology and Transplant, at the University of Toronto. He is the Director of the Cardiac Amyloid and Myeloma Clinic at Princess Margaret Hospital. He was recently appointed as the Medical Director of the Cardiac Clinical Service at the Toronto General Hospital. Dr. Delgado received his medical degree from the University of Salvador of Buenos Aires, Argentina and completed his cardiology training at Hospital Espanol in Buenos Aires. He completed two research/clinical post-doctoral fellowships in heart failure and transplantation at Rush Presbyterian St. Luke Medical Center, Chicago and at the Toronto General Hospital, and earned his Masters Degree in Clinical Epidemiology from the University of Toronto in 2006. His interests are the immunologic aspects of advanced heart failure and transplantation. Allan R. Glanville, MBBS, MD, FRACP St. Vincent's Hospital Sydney, AUSTRALIA 61-2-8382-3257 aglanville@stvincents.com.au Professor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia. James Kirkpatrick, MD University of Pennslyvania Philadelphia, Pennsylvania, USA 215-662-7726 james.kirkpatrick@uphs.upenn.edu Bio coming soon... Jacob Lavee, MD Sheba Medical Center Leviev Heart Center Tel Hashomer, ISRAEL 972-3-530-2225 jaylavee@netvision.net.il Prof. Jacob Lavee is the Director of the Heart Transplantation Unit and Deputy Director of the Department of Cardiac Surgery at the Leviev Heart Center of the Sheba Medical Center which is affiliated to the Tel Aviv University Faculty of Medicine. He received his M.D. cum laude degree from the Tel Aviv University Faculty of Medicine in Israel and was subsequently trained in cardiothoracic surgery at the Sheba Medical Center. He later trained in heart and lung transplantation at the University of Pittsburgh Medical Center and in 1991 founded the Heart Transplantation Unit at the Sheba Medical Center which since has become Israel’s largest unit of its kind. Since 1997 he has developed an active ventricular assist device program and in 2001 implanted the first-in-man HeartMate II LVAD. He is the past Chairman of the Israel Society Of Cardiothoracic Surgery, past President of the Israel Transplantation Society and currently serves as Chairman of the Heart and Lung Transplantation committee of Israel’s National Transplant Center and Israel’s representative in the Declaration of Istanbul Custodian Group. Heather J. Ross, MD, MHSc, FRCP(c) Toronto General Hospital Toronto, Ontario, CANADA 416-340-3482 heather.ross@uhn.ca Dr. Heather Ross is the Director of Heart Failure and Transplantation, Deputy Director for the MultiOrgan Transplant Program, and an Associate Professor of Medicine at the University Health Network, University of Toronto, Canada. Dr. Ross completed her Internal Medicine residency at the University of British Columbia in Vancouver, Canada. She trained in cardiology at Dalhousie, Nova Scotia, Canada, and subsequently in cardiac transplant at Stanford University, Palo Alto California. She completed her Masters in Bioethics at the University of Toronto. Josef Stehlik, MD, MPH University of Utah Salt Lake City, Utah, USA 801-585-2340 josef.stehlik@hsc.utah.edu Josef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCPHahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support. Geert M. Verleden, MD, PhD University Hospital Gasthuisberg Leuven, BELGIUM 32-16-34-68-09 geert.verleden@uzleuven.be G.M. Verleden obtained his MD degree in 1983 and his PhD in 1993, after being trained in internal medicine, pulmonary medicine and intensive care medicine. He is currently full professor of Pulmonary Medicine at the Katholieke Universiteit Leuven and at the University Hospital Gasthuisberg in Belgium. He is the medical director of the Leuven Lung Transplant programme, which was initiated in 1991. His research interests are primarily in the area of inflammation of the airways with particular interest in the role of the airway smooth muscle and the neutrophils in chronic rejection after lung transplantation and the potential role of neo-macrolides to treat this condition. Georg M. Wieselthaler, MD Univ of California San Francisco San Francisco, California, USA 415-353-9028 georg.wieselthaler@ucsfmedctr.org Bio coming soon...* Christopher H. Wigfield, MD, FRCS(C/Th) Loyola University Medical Center Maywood, Illinois, USA 708-327-2488 cwigfield@lumc.edu Christopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Thoracic and Cardiovascular Surgery at Loyola University Medical Center in Maywood, Illinois. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.
COUNCIL & COMMITTEE REPRESENTATIVES
BSTR COUNCIL REPRESENTATIVE Howard J. Eisen, MD, FAHA, FACC, FACP Drexel University College of Medicine and Hahnemann University Hospital Philadelphia, PA, USA 215-762-5080 Howard.Eisen@DrexelMed.edu Dr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine. HFTM COUNCIL REPRESENTATIVE Deborah E. Meyers, MD, FRACP, FACC Texas Heart Institute Houston, Texas, USA 832-355-9805 DMeyers@texasheart.org Deborah Meyers, MD is the Medical Director of Heart Failure Programs at Texas Heart Institute and St. Luke’s Episcopal Hospital in Houston, Texas. She is board certified in general cardiology and in advanced heart failure and transplantation. Dr. Meyers received her medical degree from the University of California, San Francisco School of Medicine where she also began her Internal Medicine residency. She completed her Cardiology Fellowship at Barnes-Jewish Hospital at Washington University in St. Louis. Dr. Meyers then traveled to Brisbane, Australia where she completed a post-graduate specialist training program at the University of Queensland, was awarded Fellowship in the Royal Australasian College of Physicians, and completed a fellowship in Heart Failure and Transplantation. In Australia, Dr. Meyers served as the Clinical Director of the Queensland Heart Failure & Transplantation Program and directed the Multidisciplinary Heart Failure Clinic at the Prince Charles Hospital in Chermside, Queensland. In 2008, she and her family returned to the United States. She continues to pursue her special interests in care delivery models, patient centered practice, medical decision making, the role of palliative services in heart failure, chronic disease management, and the relationship between physical activity and heart failure. ID COUNCIL REPRESENTATIVE Martha L. Mooney, MD Sentara Norfolk Transplant Center/EVMS Norfolk, Virginia, USA 757-388-3803 mooneyml@evms.edu Martha Mooney, MD, is an Associate Professor at Eastern Virginia Medical School (EVMS) in Norfolk, Virginia. Dr. Mooney received her medical education at EVMS and a graduate degree in Biochemical Genetics from Old Dominion University in Norfolk. She completed her residency in Internal Medicine at Eastern Virginia Graduate School of Medicine and subsequently completed a fellowship in Infectious Disease, Research and Clinical, at the Medical College of Virginia in Richmond, Virginia. JFT COUNCIL REPRESENTATIVE Reema Hasan, MD University of Michigan Cardiovascular Ann Arbor, Michigan, USA 734-232-6793 hasanr@med.umich.edu Bio coming soon... MCS COUNCIL REPRESENTATIVE Sean P. Pinney, MD Mount Sinai Medical Center New York, New York, USA 212-241-9723 sean.pinney@mssm.edu Bio coming soon... NHSAH COUNCIL REPRESENTATIVE Michael G. Petty, PhD, RN, CCNS, CNS University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, USA 612-273-5607 mpetty1@fairview.org Dr. Michael Petty is a Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Fairview. He received his nursing degree from the University of Minnesota-Twin Cities in 1996 and earned his PhD at the University of Minnesota School of Nursing in 2010. He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years. Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions. PATH COUNCIL REPRESENTATIVE Margaret M Burke, FRCPath Harefield Hospital Middlesex, UNITED KINGDOM 44-1895-828-929 m.burke@rbht.nhs.uk Bio coming soon... PEDS COUNCIL REPRESENTATIVE Anne I. Dipchand, MD Hospital for Sick Children Toronto, Ontario, CANADA 44-191-213-7499 anne.dipchand@sickkids.on.ca Anne Dipchand, MD FRCPC, is Head of the Cardiac Transplant Program and a Staff Cardiologist at the Hospital for Sick Children in Toronto. She is also an Associate Professor of Pediatrics with the University of Toronto. PHARM COUNCIL REPRESENTATIVE Patricia A. Uber, PharmD University of Maryland Baltimore, Maryland, USA 410-328-3140 puber@medicine.umaryland.edu Dr. Patricia Uber is an Assistant Professor of Medicine at the University of Maryland School of Medicine. She regularly serves on the scientific program committees for the Heart Failure Society of America as well as the International Society for Heart and Lung Transplantation. She has authored over 100 publications, including peer-reviewed original research papers, investigating new immunosuppressant regimens in heart transplantation, genetic approaches to personalized medicine, health care disparities in African-American heart transplant recipients and biomarkers in obese patients with heart failure. PH COUNCIL REPRESENTATIVE John Granton, MD University of Toronto Toronto, Ontario, CANADA 416-340-4485 john.granton@uhn.on.ca Bio coming soon... PULM TX COUNCIL REPRESENTATIVE Lianne G. Singer, MD, FRCPC Toronto General Hospital Toronto, Ontario, CANADA 416-340-4996 lianne.singer@uhn.on.ca Lianne Singer, MD, FRCPC is Medical Director of the Toronto Lung Transplant Program at the University Health Network in Toronto, Ontario, Canada. She is also Associate Professor in the Department of Medicine at the University of Toronto. She completed medical school, Internal Medicine and Respirology training at the University of Toronto. She went on to do a Lung and Heart-Lung Transplantation Fellowship at Stanford University, and advanced training in clinical research at the University of California, San Francisco. Dr. Singer's research interests arise directly from her clinical focus in lung transplantation and include health-related quality of life assessment in advanced lung disease and lung transplantation, telemedicine in lung transplantation, and clinical trials. STANDARDS & GUIDELINES COMMITTEE REPRESENTATIVE Naveen Pereira, MD Mayo Clinic Rochester, Minnesota, USA 507-538-8151 pereira.naveen@mayo.edu Naveen Periera MD, FACC is a Consultant in Cardiovascular Diseases at Mayo Clinic, Rochester specializing in advanced heart failure, mechanical circulatory support and heart, heart-lung, heart-kidney and heart-liver transplantation. His research interests include investigating the role of surrogate markers of long-term mortality in heart transplantation including cardiac allograft hypertrophy, antibody mediated rejection and anti-HLA antibodies. He is NIH funded with a focus on genetic variation of the natriuretic peptide system and its effect on the pathophysiology and treatment response in heart failure. Dr. Pereira received his medical training at the University of Bombay, India. He completed his internal medicine residency at the University of Connecticut Health Sciences Center, Farmington, CT and cardiology fellowship at Brown University, Providence, RI and Massachusetts General Hospital, Boston, MA. COMMUNICATIONS LIAISON Maryl R. Johnson, MD University of Wisconsin Madison, Wisconsin, USA 608-263-0080 mrj@medicine.wisc.edu Bio coming soon...
AMBASSADORS
AUSTRALIA Keith McNeil, FRACP Metro North Health Service District Herston, Queensland, AUSTRALIA 61-7-3328-9921 keith_mcneil@health.qld.gov.au Bio coming soon... BRAZIL Fernando A. Figueira, MD IMIP Recife, BRAZIL 55-81-9204-0308 fernando@imip.org.br Bio coming soon... CHILE Pablo F. Castro, MD Bayer Lab Santiago, CHILE 56-2-354-3624 pcastroenator@yahoo.es Bio coming soon... INDIA / USA Anantharam V. Kalya, MD Mayo Clinic Hospital Phoenix Campus Phoenix, Arizona, USA 480-342-2382 kalya.anantharam@mayo.edu Bio coming soon... IRAN Hamidreza Abtahi, MD Tehran University of Medical Sciences Imamkhomeini Medical Center Tehran, IRAN 0098-912-3278024 hrabtahi@tums.ac.ir Bio coming soon... ISRAEL Tuvia Ben Gal, MD Rabin Medical Center Petah Tikva, ISRAEL 972-522-757-616 bengaltu@gmail.com Bio coming soon... SINGAPORE Cumara C. Sivathasan, MBBS FRCS National Heart Centre Singapore, SINGAPORE 65-683-65-589 csiva@pacific.net.sg Bio coming soon... SOUTH AFRICA Graham A. Cassel, MD Milpark Hospital Johannesburg, SOUTH AFRICA 00-27-824-103-931 natalie@uwiniwin.co.za Bio coming soon...